triptorelin acetate (Ferring Pharmaceuticals)
86
Structured Review
Ferring Pharmaceuticals
triptorelin acetate
Triptorelin Acetate, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptorelin+acetate+decapeptyl/triptorelin/pm42287529-32-5-8
Average 86 stars, based on 1 article reviews
Triptorelin Acetate, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptorelin+acetate+decapeptyl/triptorelin/pm42287529-32-5-8
Average 86 stars, based on 1 article reviews
triptorelin acetate - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Formulation:Article Title: Vasodilators for women undergoing fertility treatment Article Snippet: .. Methods Double-blind parallel-group RCT Participants Participants: women with history of recurrent implantation failure after IVF Number of centres: 1 Setting: Obstetrics and Gynecology Department of Ain Shams University Country: Egypt Length of follow-up: 7 weeks Number of randomised participants: 80 women with ≥ 2 failed IVF cycles Age (mean ± SD): not reported Inclusion criteria: infertility, age 20–40 years; BMI 20–29 kg/m2; ≥ 2 implantation failures attributed to inadequate endometrial development Exclusion criteria: uterine abnormalities (e.g. septate, bicornuate, and fibroid uterus, Asherman syndrome); any contraindication to sildenafil citrate or any of the components of its formulation (including concurrent use of organic nitrites and nitrates); severe hepatic impairment; severe renal impairment; hypotension; recent stroke or heart attack Interventions Experimental group: n = 40; sildenafil citrate 25 mg tablets every 6 hours from day six of induction of ovulation until day of hCG administration Control group: n = 40; placebo tablets Both groups: ovarian hyperstimulation according to long GnRH agonist protocol starting from midluteal phase by daily subcutaneous injection of Control:Article Title: Vasodilators for women undergoing fertility treatment Article Snippet: .. Methods Double-blind parallel-group RCT Participants Participants: women with history of recurrent implantation failure after IVF Number of centres: 1 Setting: Obstetrics and Gynecology Department of Ain Shams University Country: Egypt Length of follow-up: 7 weeks Number of randomised participants: 80 women with ≥ 2 failed IVF cycles Age (mean ± SD): not reported Inclusion criteria: infertility, age 20–40 years; BMI 20–29 kg/m2; ≥ 2 implantation failures attributed to inadequate endometrial development Exclusion criteria: uterine abnormalities (e.g. septate, bicornuate, and fibroid uterus, Asherman syndrome); any contraindication to sildenafil citrate or any of the components of its formulation (including concurrent use of organic nitrites and nitrates); severe hepatic impairment; severe renal impairment; hypotension; recent stroke or heart attack Interventions Experimental group: n = 40; sildenafil citrate 25 mg tablets every 6 hours from day six of induction of ovulation until day of hCG administration Control group: n = 40; placebo tablets Both groups: ovarian hyperstimulation according to long GnRH agonist protocol starting from midluteal phase by daily subcutaneous injection of Injection:Article Title: Vasodilators for women undergoing fertility treatment Article Snippet: .. Methods Double-blind parallel-group RCT Participants Participants: women with history of recurrent implantation failure after IVF Number of centres: 1 Setting: Obstetrics and Gynecology Department of Ain Shams University Country: Egypt Length of follow-up: 7 weeks Number of randomised participants: 80 women with ≥ 2 failed IVF cycles Age (mean ± SD): not reported Inclusion criteria: infertility, age 20–40 years; BMI 20–29 kg/m2; ≥ 2 implantation failures attributed to inadequate endometrial development Exclusion criteria: uterine abnormalities (e.g. septate, bicornuate, and fibroid uterus, Asherman syndrome); any contraindication to sildenafil citrate or any of the components of its formulation (including concurrent use of organic nitrites and nitrates); severe hepatic impairment; severe renal impairment; hypotension; recent stroke or heart attack Interventions Experimental group: n = 40; sildenafil citrate 25 mg tablets every 6 hours from day six of induction of ovulation until day of hCG administration Control group: n = 40; placebo tablets Both groups: ovarian hyperstimulation according to long GnRH agonist protocol starting from midluteal phase by daily subcutaneous injection of Article Title: Successful live birth following a short course of glucocorticoid suppression in a patient with autoimmune polyglandular syndrome type 2 and premature ovarian insufficiency: A case report. Article Snippet: Correspondence Rachel Bradbury Suite 206, 151-155 Hawkesbury Road, Westmead, NSW 2145, Australia.. Email: rachel.bradbury@sydney.edu.au Abstract A 32-year-old nulliparous woman with premature ovarian insufficiency POI and autoimmune polyglandular syndrome type 2 (APS-2), presented to our fertility center with a 2.5-year history of amenorrhoea.. Controlled ovarian hyperstimulation (COH), with high dose gonadotropins, failed to promote antral follicle growth. other:Article Title: Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports Article Snippet: Case 1: On day 18 of the patient’s menstrual cycle, daily treatment was started with 0.1 mg Diagnostic Assay:Article Title: Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty Article Snippet: Before the COVID-19 pandemic, gonadorelin (Relefact ® , Sanofi-Aventis, France) was commonly used in the GnRH stimulation test; during the pandemic, however, it became short in supply, and an alternative was needed. .. Several previous studies have suggested that Article Title: Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty. Article Snippet: Before the COVID-19 pandemic, gonadorelin (Relefact®, Sanofi-Aventis, France) was commonly used in the GnRH stimulation test; during the pandemic, however, it became short in supply, and an alternative was needed. .. Several previous studies have suggested that |
